Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Marchex (MCHX) EBITDA (2016 - 2025)

Historic EBITDA for Marchex (MCHX) over the last 17 years, with Q3 2025 value amounting to -$941000.0.

  • Marchex's EBITDA fell 1406.06% to -$941000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 2396.38%. This contributed to the annual value of -$4.4 million for FY2024, which is 5388.36% up from last year.
  • Marchex's EBITDA amounted to -$941000.0 in Q3 2025, which was down 1406.06% from -$536000.0 recorded in Q2 2025.
  • Marchex's 5-year EBITDA high stood at -$536000.0 for Q2 2025, and its period low was -$5.2 million during Q1 2021.
  • Over the past 5 years, Marchex's median EBITDA value was -$1.6 million (recorded in 2024), while the average stood at -$2.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 8025.66% in 2021, then plummeted by 19412.15% in 2023.
  • Quarter analysis of 5 years shows Marchex's EBITDA stood at -$1.8 million in 2021, then crashed by 96.98% to -$3.5 million in 2022, then surged by 68.17% to -$1.1 million in 2023, then plummeted by 41.57% to -$1.6 million in 2024, then surged by 40.71% to -$941000.0 in 2025.
  • Its last three reported values are -$941000.0 in Q3 2025, -$536000.0 for Q2 2025, and -$1.9 million during Q1 2025.